US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Potassium Phosphate

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. NDC 15082-926-25 D-0954-2017
Class II · Moderate risk Terminated

Quelicin

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. NDC 15082-814-67 D-0953-2017
Class I · High risk Terminated

MAN OF STEEL capsules

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.

Vitility D-0032-2018
Class II · Moderate risk Terminated

Cyclobenzaprine HCl Tablets

Reason Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Apace KY LLC D-1036-2017
Class II · Moderate risk Terminated

Amantadine HCl Capsules

Reason Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg

Apace KY LLC D-1035-2017
Class II · Moderate risk Terminated

Succinylcholine Chloride

Reason Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier

Fagron Compounding Services LLC dba Fagron Sterile Services D-0946-2017
Class II · Moderate risk Terminated

Ibuprofen Tablets

Reason Presence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.

Time-Cap Laboratories, Inc. NDC 49483-603-50 D-1055-2017
Class III · Low risk Terminated

Amitriptyline HCl Tablets

Reason Cross Contamination With Other Product: Imipramine

Sandoz Incorporated NDC 0781-1487-01 D-0943-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-464-69 D-0941-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-463-69 D-0940-2017
Class II · Moderate risk Terminated

Clindamycin Injection USP

Reason Lack of Assurance of Sterility

Alvogen, Inc NDC 47781-462-69 D-0939-2017
Class II · Moderate risk Terminated

Morphine Sulfate Oral Solution

Reason Defective container: Oral solution leaking from container.

Tris Pharma Inc. NDC 27808-082-01 D-1126-2017
Class II · Moderate risk Terminated

Neut Sodium Bicarbonate 4%

Reason Lack of Sterility Assurance

Hospira a Pfizer Company NDC 0409-6609-02 D-1049-2017
Class II · Moderate risk Terminated

8.4% Sodium Bicarbonate Inj.

Reason Lack of Sterility Assurance

Hospira a Pfizer Company D-1047-2017
Class II · Moderate risk Terminated

Potassium Phosphates Inj.

Reason Lack of Sterility Assurance

Hospira a Pfizer Company D-1046-2017
Class II · Moderate risk Terminated

CVS Health Baby Eczema Moisturizing Cream

Reason Microbial Contamination of Non Sterile Products; out of specification Total Plate Count

Sigan Industries Inc. D-0975-2017
Class III · Low risk Terminated

Gaviscon

Reason Superpotent Drug: high out-of-specification result for magnesium.

Sanofi-Aventis U.S. LLC D-0926-2017
Class II · Moderate risk Terminated

NitroGlycerin

Reason Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Advanced Pharma Inc. NDC 15082-863-61 D-0119-2018
Class II · Moderate risk Terminated

NitroGlycerin

Reason Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Advanced Pharma Inc. NDC 15082-863-67 D-0118-2018